Sign in

CIK 0001368514 · Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562590442
Phone
(201) 478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 8-K Event Other events
  2. 8-K Event Other events
  3. 4 Open-market buy Director bought 20,000 shares at $3.50 ($70,000)
  4. 4 Open-market buy CSO and CMO bought 4,285 shares at $3.50 ($14,998)
  5. 4 Open-market buy Director bought 45,714 shares at $3.50 ($159,999)
  6. 4 Open-market buy EVP, CFO bought 7,142 shares at $3.50 ($24,997)
  7. 4 Open-market buy President and CEO bought 85,714 shares at $3.50 ($299,999)
  8. 4 Open-market buy 10% owner bought 4,563,700 shares at $3.50 ($15,972,950)
  9. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  10. 8-K Event Material agreement
  11. 424B5 Offering Prospectus
  12. SC 13G Stake Amended Statement of Ownership
  13. 424B5 Offering Prospectus
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. 8-K Event Regulation FD disclosure
  16. 8-K Event Results of operations
  17. 8-K Event Other events
  18. 8-K Event Executive or director change · Other events
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Other events

Page 24 of 50 · 1,000 filings